This trial is studying how well white blood cells taken from a person's own body, when mixed with other drugs, work in treating patients with melanoma that has spread to another place in the body.
2 Primary · 0 Secondary · Reporting Duration: Up to 5 years
30 Total Participants · 1 Treatment Group
Primary Treatment: Autologous CD8+ Melanoma Specific T Cells · No Placebo Group · Phase 2
Age 18+ · All Participants · 10 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: